Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Browse creative work from home business ideas that can help you start earning. Discover the perfect fit for your skills!
18,910 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
Investors are weighing SpaceX's first earnings as a public company against a backdrop of limited float and big hype. ...
A reported plan for Apple to source memory chips from a Chinese supplier could upend Micron’s mobile business and cha...
NVIDIA commands the AI software and platform stack, while Micron powers the memory that feeds it. Investors bet on wh...
Could Energy Transfer (ET) outpace the broad market in the second half of 2026? This article builds a practical, data...
AMD has surged in 2026 and is flirting with a $1 trillion market cap. This deep dive examines the drivers, risks, and...
Roku and Sirius XM sit at opposite ends of the media stock spectrum: one is a fast-growing platform, the other a stea...
The chip market has cooled as investors weigh AI infrastructure costs. This piece highlights three AI chip stocks to ...
PepsiCo reported higher revenue, yet its stock hovered near a 52-week low as investors weighed costs, margins, and gr...
AI-driven investment has become a major growth engine for the U.S. economy, but a slowdown could ripple across jobs, ...
Amazon stock defies volatility with strong AWS momentum and AI commitments, fueling a growing conviction among trader...
Palantir Technologies stock popped today on an earnings-tease event, not a full report. This article explains the dri...